ATP10D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.280470E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.057990E-01
Normal-vs-Stage2
1.196050E-02
Normal-vs-Stage3
1.525450E-01
Normal-vs-Stage4
4.253200E-01
Stage1-vs-Stage2
7.597600E-01
Stage1-vs-Stage3
1.247780E-01
Stage1-vs-Stage4
3.568400E-01
Stage2-vs-Stage3
5.575200E-03
Stage2-vs-Stage4
1.907170E-01
Stage3-vs-Stage4
1.003770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.079700E-03
Normal-vs-AfricanAmerican
4.727000E-01
Normal-vs-Asian
9.603900E-03
Caucasian-vs-AfricanAmerican
3.949400E-01
Caucasian-vs-Asian
1.150250E-01
AfricanAmerican-vs-Asian
8.222300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.363700E-02
Normal-vs-Female
7.822600E-03
Male-vs-Female
8.011600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.159400E-01
Normal-vs-Age(41-60Yrs)
3.412500E-02
Normal-vs-Age(61-80Yrs)
1.436260E-02
Normal-vs-Age(81-100Yrs)
1.838790E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.977800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.661000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.078200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.554400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.666200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.241800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.715900E-03
Normal-vs-Daily Drinker
1.669570E-01
Normal-vs-Weekly Drinker
2.543600E-02
Normal-vs-Occasional Drinker
5.364100E-02
Normal-vs-Social Drinker
3.046200E-01
Non Drinker-vs-Daily Drinker
4.169200E-01
Non Drinker-vs-Weekly Drinker
7.039200E-01
Non Drinker-vs-Occasional Drinker
3.029200E-01
Non Drinker-vs-Social Drinker
5.569600E-02
Daily Drinker-vs-Weekly Drinker
2.893200E-01
Daily Drinker-vs-Occasional Drinker
1.207390E-01
Daily Drinker-vs-Social Drinker
2.187800E-02
Weekly Drinker-vs-Occasional Drinker
6.201400E-01
Weekly Drinker-vs-Social Drinker
1.325450E-01
Occasional Drinker-vs-Social Drinker
2.470400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.434600E-01
Normal-vs-Grade 2
3.350400E-01
Normal-vs-Grade 3
3.335400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.727800E-01
Grade 1-vs-Grade 3
3.287200E-01
Grade 1-vs-Grade 4
5.434600E-01
Grade 2-vs-Grade 3
4.257000E-01
Grade 2-vs-Grade 4
3.350400E-01
Grade 3-vs-Grade 4
3.335400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.866260E-02
Normal-vs-NonDiabetic
7.016400E-03
Diabetic-vs-NonDiabetic
9.462600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.819050E-01
Normal-vs-NoPancreatitis
1.213960E-02
Pancreatitis-vs-NoPancreatitis
3.164400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.206500E-02
Normal-vs-N1
1.231600E-02
N0-vs-N1
6.464000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.540310E-02
Normal-vs-TP53-NonMutant
1.134160E-01
TP53-Mutant-vs-TP53-NonMutant
1.228830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
